Cargando…

GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings

INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadesse, Mulualem, Abebe, Gemeda, Abdissa, Ketema, Aragaw, Dossegnaw, Abdella, Kedir, Bekele, Alemayehu, Bezabih, Mesele, Apers, Ludwig, de Jong, Bouke C., Rigouts, Leen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569183/
https://www.ncbi.nlm.nih.gov/pubmed/26366871
http://dx.doi.org/10.1371/journal.pone.0137471
_version_ 1782390001775935488
author Tadesse, Mulualem
Abebe, Gemeda
Abdissa, Ketema
Aragaw, Dossegnaw
Abdella, Kedir
Bekele, Alemayehu
Bezabih, Mesele
Apers, Ludwig
de Jong, Bouke C.
Rigouts, Leen
author_facet Tadesse, Mulualem
Abebe, Gemeda
Abdissa, Ketema
Aragaw, Dossegnaw
Abdella, Kedir
Bekele, Alemayehu
Bezabih, Mesele
Apers, Ludwig
de Jong, Bouke C.
Rigouts, Leen
author_sort Tadesse, Mulualem
collection PubMed
description INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0–94.5] and specificity 91.1% [95% CI: 82.8–99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates.
format Online
Article
Text
id pubmed-4569183
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45691832015-09-18 GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings Tadesse, Mulualem Abebe, Gemeda Abdissa, Ketema Aragaw, Dossegnaw Abdella, Kedir Bekele, Alemayehu Bezabih, Mesele Apers, Ludwig de Jong, Bouke C. Rigouts, Leen PLoS One Research Article INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0–94.5] and specificity 91.1% [95% CI: 82.8–99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates. Public Library of Science 2015-09-14 /pmc/articles/PMC4569183/ /pubmed/26366871 http://dx.doi.org/10.1371/journal.pone.0137471 Text en © 2015 Tadesse et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tadesse, Mulualem
Abebe, Gemeda
Abdissa, Ketema
Aragaw, Dossegnaw
Abdella, Kedir
Bekele, Alemayehu
Bezabih, Mesele
Apers, Ludwig
de Jong, Bouke C.
Rigouts, Leen
GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title_full GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title_fullStr GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title_full_unstemmed GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title_short GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
title_sort genexpert mtb/rif assay for the diagnosis of tuberculous lymphadenitis on concentrated fine needle aspirates in high tuberculosis burden settings
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569183/
https://www.ncbi.nlm.nih.gov/pubmed/26366871
http://dx.doi.org/10.1371/journal.pone.0137471
work_keys_str_mv AT tadessemulualem genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT abebegemeda genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT abdissaketema genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT aragawdossegnaw genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT abdellakedir genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT bekelealemayehu genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT bezabihmesele genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT apersludwig genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT dejongboukec genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings
AT rigoutsleen genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings